KalVista Pharmaceuticals (KALV) Return on Equity (2015 - 2025)

KalVista Pharmaceuticals' Return on Equity history runs 11 years deep, the most recent figure standing at 0.01% for Q3 2025.

• In Q3 2025, Return on Equity fell 1.0% year-over-year to 0.01%; the TTM figure through Jul 2025 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 0.01% for Q3 2025 at KalVista Pharmaceuticals, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q3 2021 to a low of 0.01% in Q1 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Equity.
• Across the five-year window, Return on Equity changed 0 bps in 2021 and retreated 1 bps in 2024, its largest moves.
• KalVista Pharmaceuticals' Return on Equity stood at 0.0% in 2021, then sank by 120 bps to 0.01% in 2022, then plunged by 33 bps to 0.01% in 2023, then jumped by 59 bps to 0.0% in 2024, then slumped by 157 bps to 0.01% in 2025.
• According to Business Quant data, Return on Equity over the past three periods registered 0.01%, 0.0%, and 0.0% for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison